Patients with NAFLD had significantly higher (p < 0001) mean values of urinary 8-iso-PGF2α and of serum sNOX2-dp, ALT, CK-18 and HOMA-IR and lower values of serum adiponectin. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.